Developer docs
API playgroundTry for free, no card

Search company profiles

ISTH

Full company profile

uuid000b6ea

Namestring
ISTH
Legal namestring
International Society on Thrombosis and Haemostasis, Inc.
Websiteurl
isth.org
Company typeenum
Private
Founded yearint
1954
Descriptiontext

ISTH is a nonprofit professional society, incorporated in North Carolina (USA) and headquartered in Carrboro, that serves the global thrombosis and hemostasis clinical and research community. The society's core offerings are organized around three pillars: two peer-reviewed journals (the Journal of Thrombosis and Haemostasis, JTH, and Research and Practice in Thrombosis and Haemostasis, RPTH); an annual international congress drawing attendees from 100+ countries; and a Scientific and Standardization Committee (SSC) comprising 21 subcommittees that develop nomenclature, standards, and reference materials — including the Secondary Coagulation Standard Plasma calibrated against WHO International Standards.

The platform architecture spans the ISTH Academy (e-learning with webinars, courses, CME), My ISTH Community (member portal), REDCap-based clinical registries, and CoagBase (a coagulation and platelet protein/gene reference database with HGVS conversion tooling). Supporting programs include World Thrombosis Day (global awareness campaign observed October 13), the Reach-the-World fellowship program for developing countries, clinical practice guidelines, the SSC on the Case virtual learning series, and a Gene Therapy in Hemophilia portal.

Revenue is generated through a diversified nonprofit model: tiered membership dues (Premier $180/year to free student), congress registration, journal licensing, educational program fees, content licensing to pharmaceutical/medical device companies and CME providers, industry sponsorships (including an Industry Roundtable with partners such as Roche, Pfizer, Novo Nordisk, Novartis, BMS, J&J, Sobi, Regeneron, STAR Therapeutics), and donations. With 7,700+ members in 110+ countries and a ~30-person staff, the organization operates as a member-driven, governance-led society.

Short descriptiontext

ISTH is a nonprofit professional society serving 7,700+ clinicians, researchers, and healthcare professionals in 110+ countries through two peer-reviewed journals, an annual congress, and the Scientific and Standardization Committee, which sets WHO-adopted standards for thrombosis and hemostasis.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCarrboro, United States
HQ citystring
Carrboro
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
thrombosis and hemostasis research, medical professional society, clinical practice guidelines, peer-reviewed medical journals, continuing medical education
Industry1 code
1Therapeutic Enzymes & Enzyme Replacement Therapies (ERT)
CodeHLAAAAAKPrimaryYes
NAICS code1 code
  • Libraries and Archives51921
SIC code1 code
  • Services-Membership Organizations8600
Product category
Medical Professional Society
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model6 records
1Membership Dues
TypeSubscription Recurring
Description

Annual membership fees ranging from free for students to $180 for premier members, providing access to member benefits, journals, and community

isth.org
2Congress Registration
TypeSubscription Recurring
Description

Revenue from ISTH annual congress registration fees, including the ISTH 2026 Congress in Chicago and ISTH 2027 in Vancouver

isth.org
3Journal Publications
TypeSubscription Recurring
Description

Official journals - Journal of Thrombosis and Haemostasis (JTH) and Research and Practice in Thrombosis and Haemostasis (RPTH) - serve as authoritative resources

isth.org
4Educational Programs
TypeSubscription Recurring
Description

Revenue from online courses, CME modules, and educational content through ISTH Academy platform

isth.org
5Content Licensing
TypeLicensing Royalties
Description

Licensing of educational content, webinars, meeting recordings, and clinical practice guidelines to pharmaceutical companies, medical device companies, publishers, and CME providers

isth.org
6Donations and Fundraising
TypeSubscription Recurring
Description

Donations to various funds including General Fund, Early Career Support, Fundamental Research, and World Thrombosis Day

isth.org
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details10 tiers
1Premier Member - Full professional membership with all benefits
ModelSubscriptionBilling cadenceAnnual
Notes

$180/year for individual Premier membership; 2-year: $350; 3-year: $525

isth.org
2Advanced Practice Provider / Pharmacist
ModelSubscriptionBilling cadenceAnnual
Notes

$120/year; 2-year: $230; 3-year: $345

isth.org
3Associate Member - Post clinical training professionals
ModelSubscriptionBilling cadenceAnnual
Notes

$90/year

isth.org
4Medical Resident/Post Doc
ModelSubscriptionBilling cadenceAnnual
Notes

$35/year

isth.org
5Reach-the-World - Members from developing countries
ModelSubscriptionBilling cadenceAnnual
Notes

$35/year; 2-year: $65; 3-year: $100

isth.org
6Nurse
ModelSubscriptionBilling cadenceAnnual
Notes

$35/year; 2-year: $65; 3-year: $100

isth.org
7Allied Health Professional
ModelSubscriptionBilling cadenceAnnual
Notes

$35/year

isth.org
8Student/Trainee
ModelFreemiumBilling cadenceAnnual
Notes

FREE membership for students and trainees

isth.org
9ISTH Academy - Limited access
ModelFreemiumBilling cadenceAnnual
Notes

Free limited access to live and archived webinars, online courses and selected content; no additional member benefits

isth.org
10Emeritus - Retired professionals (10+ year members)
ModelFreemiumBilling cadenceAnnual
Notes

Free membership; optional $35 for JTH access

isth.org
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1World Thrombosis Day
Description

An education and awareness initiative aimed at saving lives across the globe by raising awareness about thrombosis and its prevention.

isth.org
+1 more record
Core offering1 text field

ISTH is a nonprofit professional society that advances the prevention, diagnosis, and treatment of thrombotic and bleeding disorders. It sells tiered memberships, publishes two peer-reviewed journals (JTH and RPTH), operates the annual ISTH Congress, runs the ISTH Academy e-learning platform, manages the Scientific and Standardization Committee (SSC) with 21 subcommittees, and licenses educational content and WHO-aligned standards to industry and CME partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Standards developed by the SSC have been adopted by WHO as International Standards
+1 more record
Product overview1 text field

ISTH is a nonprofit professional society offering a comprehensive ecosystem of products and services for the thrombosis and hemostasis community. The core offerings include two peer-reviewed journals (Journal of Thrombosis and Haemostasis and Research and Practice in Thrombosis and Haemostasis), the annual ISTH Congress, and the Scientific and Standardization Committee with 21 subcommittees developing standards and nomenclature. Education is delivered through the ISTH Academy (webinars, courses, CME), while awareness is driven by World Thrombosis Day. The society also provides clinical support through SSC on the Case conferences, clinical practice guidelines, guidance documents, and the CoagBase reference database. Career development is facilitated through the Career Center, Skills Directory, awards program, research grants, and the Reach-the-World Program for developing countries. Additional offerings include the ISTH Pulse Podcast, Gene Therapy in Hemophilia portal, My ISTH Community member platform, and branded resources through the Brand Toolbox.

Product and service11 records
1Journal of Thrombosis and Haemostasis (JTH)
CategoryPeer-reviewed medical journals
Description

Official peer-reviewed journal of the ISTH publishing basic, clinical, and translational research in thrombosis, bleeding disorders, and vascular biology for clinicians, researchers, and scientists worldwide.

2Research and Practice in Thrombosis and Haemostasis (RPTH)
CategoryPeer-reviewed medical journals
Description

Official peer-reviewed open-access journal of the ISTH providing authoritative resources for advancing understanding and clinical practice related to thrombotic and bleeding disorders.

3ISTH Academy
CategoryContinuing medical education
Description

Online e-learning platform providing webinars, online courses, learning modules, and access to archived presentations from past meetings, with CME credits, for healthcare professionals in thrombosis and hemostasis.

4ISTH Congress
CategoryProfessional conferences and events
Description

Annual international congress bringing together thousands of clinicians, scientists, researchers, and healthcare professionals from 100+ countries to share the latest research in thrombosis and hemostasis.

5World Thrombosis Day
CategoryPublic health awareness campaign
Description

Annual global awareness campaign observed on October 13 to raise awareness and promote prevention of thrombosis worldwide, supported by healthcare organizations, patient groups, and industry partners.

6ISTH Membership
CategoryProfessional society membership
Description

Tiered annual membership program (Student/Trainee free; Medical Resident/Post Doc $35; Reach-the-World, Nurse, Allied Health $35; Associate $90; Advanced Practice Provider/Pharmacist $120; Premier $180) providing access to journals, education, congress, community, and SSC participation.

7SSC Research Grants
CategoryResearch grants
Description

Funding program supporting innovative SSC projects with Small Grants (up to $20,000 USD) and Large Grants ($50,000 USD) for thrombosis and hemostasis research.

8CoagBase
CategoryReference databases
Description

Reference database containing coagulation and platelet proteins and genes, protein features, reference sequences, and conversion tools for legacy to HGVS amino acid numbering.

9ISTH Pulse Podcast
CategoryProfessional multimedia content
Description

Podcast featuring discussions on thrombosis and hemostasis topics for professional development and knowledge sharing among clinicians and researchers.

10Gene Therapy in Hemophilia Portal
CategorySpecialty clinical resource portal
Description

Dedicated online portal providing resources and information on gene therapy developments in hemophilia for clinicians and researchers.

11ISTH Career Center
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ISTH's SSC develops standards that are adopted by WHO as International Standards. The society collaborates with WHO on standards for blood clotting factors and coagulation testing, with many SSC-developed standards becoming the global reference.

2European Thrombosis and Haemostasis Alliance (ETHA)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ISTH partners with ETHA on advocacy and policy initiatives for thrombosis and hemostasis in Europe.

isth.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NIBSC serves as WHO International Laboratory for Biological Standards and collaborates with ISTH on the SSC Secondary Coagulation Standard Plasma. NIBSC handles storage, labeling, and dispatch of the standard.

4World Thrombosis Day Partners
Strategic tierCoreTypeGTM or Marketing Partner
Description

World Thrombosis Day is an initiative of ISTH that partners with healthcare organizations, patient groups, and industry to raise awareness about thrombosis globally on October 13 each year.

isth.org
Strategic tierMinorTypeGTM or Marketing Partner
Description

ISTH has industry partnerships with Roche, Pfizer, Novo Nordisk, Novartis, BMS, J&J, Sobi, Regeneron, and STAR Therapeutics. These partnerships support congress sponsorship, educational content, and member programs.

6Related Societies Network
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ISTH maintains a global network of related societies in thrombosis and hemostasis research and clinical practice worldwide, facilitating international collaboration and knowledge exchange.

isth.org
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partners include pharmaceutical companies, laboratory equipment/diagnostics companies, third-party distributors, publishers, CME providers, library aggregators, medical education companies, medical insurance companies, government entities, and health systems.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1International Society of Hematology (ISH)
TypeDirect peer
Description

ISH is a global hematology professional society focused on education and international collaboration across all hematology subspecialties. Comparable in mission and member-based structure, though broader in scope than ISTH.

TypeBroad incumbent
Description

ESC represents European cardiology and produces guidelines that intersect with ISTH's atrial fibrillation, anticoagulation, and venous thromboembolism guidance. Comparable as a specialty society publisher of journals and guidelines with industry-supported congresses.

TypeEmerging player
Description

SVM is a smaller US-based society focused on vascular medicine with meaningful overlap on venous thromboembolism and anticoagulation topics. Comparable in member-based non-profit structure and clinical guideline activity but smaller scale.

TypeDirect peer
Description

EHA is the principal European hematology society, publishing HemaSphere and running the annual EHA Congress. It overlaps with ISTH on European hematology professionals, joint educational programming, and clinical guideline development.

5International Society on Thrombosis and Haemostasis - direct society peers via related societies network
TypeOthers
Description

ISTH maintains a global network of related national thrombosis and hemostasis societies (e.g., Italian, German, Japanese societies) that compete for local membership but collaborate on international standards and meetings. These are the closest functional equivalents in their respective geographies.

TypeBroad incumbent
Description

AHA is a major cardiovascular professional society and publisher of Circulation and Stroke journals, with significant overlap on arterial thrombosis, stroke, and anticoagulation guidelines. Comparable in journals, congresses, and pharma-funded education, but broader in scope.

TypeBroad incumbent
Description

ASH is the largest hematology professional society in the world, with ~18,000 members, publishing Blood journal and hosting a major annual meeting. ISTH sits adjacent as a thrombosis/hemostasis-focused sub-specialty society, with overlapping clinical and research audiences.

TypeRegional player
Description

BSH is the UK's national hematology society, publishing the British Journal of Haematology and running an annual scientific meeting. Comparable in mission but primarily serves UK clinicians and overlaps with ISTH on guideline development.

TypeDirect peer
Description

WFH is a global non-profit focused specifically on hemophilia and other inherited bleeding disorders, serving national member organizations in 100+ countries. Highly comparable to ISTH's bleeding-disorder standardization, congress, and global training activities.

TypeEmerging player
Description

The Anticoagulation Forum is a US non-profit multidisciplinary organization dedicated to improving anticoagulation care. It overlaps with ISTH on antithrombotic therapy education, clinical guidance, and industry-supported programming, but with a narrower clinical focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ISTH

Medical Professional Societyisth.org

ISTH is a nonprofit professional society serving 7,700+ clinicians, researchers, and healthcare professionals in 110+ countries through two peer-reviewed journals, an annual congress, and the Scientific and Standardization Committee, which sets WHO-adopted standards for thrombosis and hemostasis.

What ISTH does

ISTH is a nonprofit professional society, incorporated in North Carolina (USA) and headquartered in Carrboro, that serves the global thrombosis and hemostasis clinical and research community. The society's core offerings are organized around three pillars: two peer-reviewed journals (the Journal of Thrombosis and Haemostasis, JTH, and Research and Practice in Thrombosis and Haemostasis, RPTH); an annual international congress drawing attendees from 100+ countries; and a Scientific and Standardization Committee (SSC) comprising 21 subcommittees that develop nomenclature, standards, and reference materials — including the Secondary Coagulation Standard Plasma calibrated against WHO International Standards.

The platform architecture spans the ISTH Academy (e-learning with webinars, courses, CME), My ISTH Community (member portal), REDCap-based clinical registries, and CoagBase (a coagulation and platelet protein/gene reference database with HGVS conversion tooling). Supporting programs include World Thrombosis Day (global awareness campaign observed October 13), the Reach-the-World fellowship program for developing countries, clinical practice guidelines, the SSC on the Case virtual learning series, and a Gene Therapy in Hemophilia portal.

Revenue is generated through a diversified nonprofit model: tiered membership dues (Premier $180/year to free student), congress registration, journal licensing, educational program fees, content licensing to pharmaceutical/medical device companies and CME providers, industry sponsorships (including an Industry Roundtable with partners such as Roche, Pfizer, Novo Nordisk, Novartis, BMS, J&J, Sobi, Regeneron, STAR Therapeutics), and donations. With 7,700+ members in 110+ countries and a ~30-person staff, the organization operates as a member-driven, governance-led society.

ISTH firmographics

Firmographics
Name
ISTH
Legal name
International Society on Thrombosis and Haemostasis, Inc.
Website
https://isth.org
Company type
Private
Founded year
1954
Operating status
Operating
Headcount range
11–50 employees
Short description
ISTH is a nonprofit professional society serving 7,700+ clinicians, researchers, and healthcare professionals in 110+ countries through two peer-reviewed journals, an annual congress, and the Scientific and Standardization Committee, which sets WHO-adopted standards for thrombosis and hemostasis.
Ownership category
akta.pro rank

ISTH industry classification

Industry
Product category
Medical Professional Society
NAICS
Libraries and Archives (51921)
SIC
Services-Membership Organizations (8600)
akta.pro primary industry
Therapeutic Enzymes & Enzyme Replacement Therapies (ERT) (HLAAAAAK)

Keywords

  • Thrombosis and hemostasis research
  • Medical professional society
  • Clinical practice guidelines
  • Peer-reviewed medical journals
  • Continuing medical education

Where ISTH is headquartered

Location

Headquarters

HQ city
Carrboro
HQ country
United States
HQ region
North America

Offices3 records

Markets served

ISTH business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Membership Dues: Annual membership fees ranging from free for students to $180 for premier members, providing access to member benefits, journals, and community
  2. Congress Registration: Revenue from ISTH annual congress registration fees, including the ISTH 2026 Congress in Chicago and ISTH 2027 in Vancouver
  3. Journal Publications: Official journals - Journal of Thrombosis and Haemostasis (JTH) and Research and Practice in Thrombosis and Haemostasis (RPTH) - serve as authoritative resources
  4. Educational Programs: Revenue from online courses, CME modules, and educational content through ISTH Academy platform
  5. Content Licensing: Licensing of educational content, webinars, meeting recordings, and clinical practice guidelines to pharmaceutical companies, medical device companies, publishers, and CME providers
  6. Donations and Fundraising: Donations to various funds including General Fund, Early Career Support, Fundamental Research, and World Thrombosis Day

Pricing tiers

ModelBillingPrice
SubscriptionAnnualPremier Member - Full professional membership with all benefits
SubscriptionAnnualAdvanced Practice Provider / Pharmacist
SubscriptionAnnualAssociate Member - Post clinical training professionals
SubscriptionAnnualMedical Resident/Post Doc
SubscriptionAnnualReach-the-World - Members from developing countries
SubscriptionAnnualNurse
SubscriptionAnnualAllied Health Professional
FreemiumAnnualStudent/Trainee
FreemiumAnnualISTH Academy - Limited access
FreemiumAnnualEmeritus - Retired professionals (10+ year members)

Go-to-market motion1 record

Distribution channels5 records

Marketing channels10 records

ISTH product offering

Product offering

Core offering

ISTH is a nonprofit professional society that advances the prevention, diagnosis, and treatment of thrombotic and bleeding disorders. It sells tiered memberships, publishes two peer-reviewed journals (JTH and RPTH), operates the annual ISTH Congress, runs the ISTH Academy e-learning platform, manages the Scientific and Standardization Committee (SSC) with 21 subcommittees, and licenses educational content and WHO-aligned standards to industry and CME partners.

Product overview

ISTH is a nonprofit professional society offering a comprehensive ecosystem of products and services for the thrombosis and hemostasis community. The core offerings include two peer-reviewed journals (Journal of Thrombosis and Haemostasis and Research and Practice in Thrombosis and Haemostasis), the annual ISTH Congress, and the Scientific and Standardization Committee with 21 subcommittees developing standards and nomenclature. Education is delivered through the ISTH Academy (webinars, courses, CME), while awareness is driven by World Thrombosis Day. The society also provides clinical support through SSC on the Case conferences, clinical practice guidelines, guidance documents, and the CoagBase reference database. Career development is facilitated through the Career Center, Skills Directory, awards program, research grants, and the Reach-the-World Program for developing countries. Additional offerings include the ISTH Pulse Podcast, Gene Therapy in Hemophilia portal, My ISTH Community member platform, and branded resources through the Brand Toolbox.

Differentiator

Problem solved

Functional benefit

Brands

  • World Thrombosis Day: An education and awareness initiative aimed at saving lives across the globe by raising awareness about thrombosis and its prevention.
  • ISTH Academy

Products and services

  • Journal of Thrombosis and Haemostasis (JTH) Official peer-reviewed journal of the ISTH publishing basic, clinical, and translational research in thrombosis, bleeding disorders, and vascular biology for clinicians, researchers, and scientists worldwide.
  • Research and Practice in Thrombosis and Haemostasis (RPTH) Official peer-reviewed open-access journal of the ISTH providing authoritative resources for advancing understanding and clinical practice related to thrombotic and bleeding disorders.
  • ISTH Academy Online e-learning platform providing webinars, online courses, learning modules, and access to archived presentations from past meetings, with CME credits, for healthcare professionals in thrombosis and hemostasis.
  • ISTH Congress Annual international congress bringing together thousands of clinicians, scientists, researchers, and healthcare professionals from 100+ countries to share the latest research in thrombosis and hemostasis.
  • World Thrombosis Day Annual global awareness campaign observed on October 13 to raise awareness and promote prevention of thrombosis worldwide, supported by healthcare organizations, patient groups, and industry partners.
  • ISTH Membership Tiered annual membership program (Student/Trainee free; Medical Resident/Post Doc $35; Reach-the-World, Nurse, Allied Health $35; Associate $90; Advanced Practice Provider/Pharmacist $120; Premier $180) providing access to journals, education, congress, community, and SSC participation.
  • SSC Research Grants Funding program supporting innovative SSC projects with Small Grants (up to $20,000 USD) and Large Grants ($50,000 USD) for thrombosis and hemostasis research.
  • CoagBase Reference database containing coagulation and platelet proteins and genes, protein features, reference sequences, and conversion tools for legacy to HGVS amino acid numbering.
  • ISTH Pulse Podcast Podcast featuring discussions on thrombosis and hemostasis topics for professional development and knowledge sharing among clinicians and researchers.
  • Gene Therapy in Hemophilia Portal Dedicated online portal providing resources and information on gene therapy developments in hemophilia for clinicians and researchers.
  • ISTH Career Center

Quantifiable outcome

  • Standards developed by the SSC have been adopted by WHO as International Standards
  • +1 more outcomes

Companies that use ISTH

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles4 records

ISTH technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

Feature5 records

ISTH partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • World Health Organization (WHO)coreStrategic or Co-development PartnerISTH's SSC develops standards that are adopted by WHO as International Standards. The society collaborates with WHO on standards for blood clotting factors and coagulation testing, with many SSC-developed standards becoming the global reference.
  • European Thrombosis and Haemostasis Alliance (ETHA)coreStrategic or Co-development PartnerISTH partners with ETHA on advocacy and policy initiatives for thrombosis and hemostasis in Europe.
  • National Institute for Biological Standards and Control (NIBSC)coreStrategic or Co-development PartnerNIBSC serves as WHO International Laboratory for Biological Standards and collaborates with ISTH on the SSC Secondary Coagulation Standard Plasma. NIBSC handles storage, labeling, and dispatch of the standard.
  • World Thrombosis Day PartnerscoreGTM or Marketing PartnerWorld Thrombosis Day is an initiative of ISTH that partners with healthcare organizations, patient groups, and industry to raise awareness about thrombosis globally on October 13 each year.
  • Pharmaceutical and Biotech Companies (Industry Partners)minorGTM or Marketing PartnerISTH has industry partnerships with Roche, Pfizer, Novo Nordisk, Novartis, BMS, J&J, Sobi, Regeneron, and STAR Therapeutics. These partnerships support congress sponsorship, educational content, and member programs.
  • Related Societies NetworkcoreStrategic or Co-development PartnerISTH maintains a global network of related societies in thrombosis and hemostasis research and clinical practice worldwide, facilitating international collaboration and knowledge exchange.
  • Content Licensing PartnersminorChannel Partner/ Reseller/ DistributorPartners include pharmaceutical companies, laboratory equipment/diagnostics companies, third-party distributors, publishers, CME providers, library aggregators, medical education companies, medical insurance companies, government entities, and health systems.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

ISTH competitors and assessment

Company assessment

Direct peers

  • International Society of Hematology (ISH): ISH is a global hematology professional society focused on education and international collaboration across all hematology subspecialties. Comparable in mission and member-based structure, though broader in scope than ISTH.
  • European Hematology Association (EHA): EHA is the principal European hematology society, publishing HemaSphere and running the annual EHA Congress. It overlaps with ISTH on European hematology professionals, joint educational programming, and clinical guideline development.
  • World Federation of Hemophilia (WFH): WFH is a global non-profit focused specifically on hemophilia and other inherited bleeding disorders, serving national member organizations in 100+ countries. Highly comparable to ISTH's bleeding-disorder standardization, congress, and global training activities.

Broad incumbents

  • European Society of Cardiology (ESC): ESC represents European cardiology and produces guidelines that intersect with ISTH's atrial fibrillation, anticoagulation, and venous thromboembolism guidance. Comparable as a specialty society publisher of journals and guidelines with industry-supported congresses.
  • American Heart Association (AHA): AHA is a major cardiovascular professional society and publisher of Circulation and Stroke journals, with significant overlap on arterial thrombosis, stroke, and anticoagulation guidelines. Comparable in journals, congresses, and pharma-funded education, but broader in scope.
  • American Society of Hematology (ASH): ASH is the largest hematology professional society in the world, with ~18,000 members, publishing Blood journal and hosting a major annual meeting. ISTH sits adjacent as a thrombosis/hemostasis-focused sub-specialty society, with overlapping clinical and research audiences.

Emerging players

  • Society for Vascular Medicine: SVM is a smaller US-based society focused on vascular medicine with meaningful overlap on venous thromboembolism and anticoagulation topics. Comparable in member-based non-profit structure and clinical guideline activity but smaller scale.
  • Anticoagulation Forum: The Anticoagulation Forum is a US non-profit multidisciplinary organization dedicated to improving anticoagulation care. It overlaps with ISTH on antithrombotic therapy education, clinical guidance, and industry-supported programming, but with a narrower clinical focus.

Others

  • International Society on Thrombosis and Haemostasis - direct society peers via related societies network: ISTH maintains a global network of related national thrombosis and hemostasis societies (e.g., Italian, German, Japanese societies) that compete for local membership but collaborate on international standards and meetings. These are the closest functional equivalents in their respective geographies.

Regional players

  • British Society for Haematology (BSH): BSH is the UK's national hematology society, publishing the British Journal of Haematology and running an annual scientific meeting. Comparable in mission but primarily serves UK clinicians and overlaps with ISTH on guideline development.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ISTH social profiles

Digital presence

ISTH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ISTH leadership team

Management profile

Number of profiles

Profiles6 records

ISTH funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ISTH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ISTH

What does ISTH do?

ISTH is a nonprofit professional society that advances the prevention, diagnosis, and treatment of thrombotic and bleeding disorders. It sells tiered memberships, publishes two peer-reviewed journals (JTH and RPTH), operates the annual ISTH Congress, runs the ISTH Academy e-learning platform, manages the Scientific and Standardization Committee (SSC) with 21 subcommittees, and licenses educational content and WHO-aligned standards to industry and CME partners.

Is ISTH a public or private company?

ISTH is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was ISTH founded?

ISTH was founded in 1954. It employs 11 to 50 people.

Where is ISTH based?

ISTH is headquartered in Carrboro, United States, in the North America region.

How does ISTH make money?

Six revenue lines are on record. Membership Dues are the primary driver. The others are congress Registration, journal Publications, educational Programs, content Licensing and donations and Fundraising.

Who are ISTH's main competitors?

Direct peers on record are International Society of Hematology (ISH), European Hematology Association (EHA) and World Federation of Hemophilia (WFH). Broad incumbents are European Society of Cardiology (ESC), American Heart Association (AHA) and American Society of Hematology (ASH). Emerging players are Society for Vascular Medicine and Anticoagulation Forum. International Society on Thrombosis and Haemostasis - direct society peers via related societies network is listed as an others. British Society for Haematology (BSH) is listed as a regional player.

Does ISTH have an API?

No public API is recorded for ISTH.

What industry is ISTH in?

ISTH's product category is Medical Professional Society. Its primary akta.pro industry code is HLAAAAAK, Therapeutic Enzymes & Enzyme Replacement Therapies (ERT). Its NAICS code is 51921 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireISTH selects Vancouver to host its 2027 CongressThe International Society on Thrombosis and Haemostasis (ISTH) has selected Vancouver, Canada to host its 2027 Congress from June 26-30, 2027. The congress will take place at the Vancouver Convention Centre and is expected to attract thousands of leading clinicians, scientists, researchers, and healthcare professionals from more than 100 countries. ISTH President Pantep Angchaisuksiri and ACPC Chair Marc Carrier expressed enthusiasm about the venue and its scientific programming.PR NewswireISTH marks World Thrombosis Day with urgent global call to actionThe International Society on Thrombosis and Haemostasis (ISTH) marked World Thrombosis Day on October 13, 2025, launching its annual global campaign to raise awareness about blood clots as a leading cause of death worldwide. The campaign highlights that thrombosis contributes to one in four deaths globally each year, with an estimated 10 million hospital-associated blood clot cases occurring annually, resulting in up to 100,000 preventable deaths in the United States alone. This year's theme "From Head to Toe, Take Control" calls on healthcare professionals, policymakers, and communities to implement risk assessment and prevention measures to reduce the global burden of thrombosis.NewswireISTH marks World Thrombosis Day with urgent global call to actionThe International Society on Thrombosis and Haemostasis (ISTH) marked World Thrombosis Day on October 13, 2025, launching its annual global awareness campaign under the theme "From Head to Toe, Take Control. Prevent Thrombosis. Protect Your Health" to raise awareness about blood clots affecting people in more than 120 countries. The campaign highlights that thrombosis contributes to 1 in 4 deaths worldwide annually, with approximately 10 million hospital-associated blood clot cases occurring each year and up to 100,000 deaths in the United States alone. The ISTH is urging healthcare professionals to assess patient risk and implement preventive measures, while inviting policymakers and patient groups to support education and outreach efforts year-round.PR NewswireWorld Thrombosis Day encourages public to "Move Against Thrombosis" to celebrate 10 years of raising awareness worldwideThe International Society on Thrombosis and Haemostasis (ISTH) is observing World Thrombosis Day, its 10th anniversary, by launching a global awareness campaign titled "Move Against Thrombosis" involving 5,000 partner organizations across 120 countries. The initiative aims to educate the public on recognizing symptoms of blood clots, such as deep vein thrombosis and pulmonary embolism, which are often mistaken for other conditions. Key risk factors highlighted include extended hospitalization, cancer treatment, and pregnancy.PR NewswireWorld Thrombosis Day encourages public to "Move Against Thrombosis" to celebrate 10 years of raising awareness worldwideThe International Society on Thrombosis and Haemostasis (ISTH) is marking the 10th anniversary of World Thrombosis Day with a global campaign encouraging people to 'Move Against Thrombosis' through walking and stretching to increase blood flow and prevent blood clots. The campaign engages 5,000 partner organizations across 120 countries to raise awareness about thrombosis, which causes one in four deaths worldwide. Key risk factors highlighted include hospitalization (accounting for 60% of venous thromboembolism cases) and cancer treatment, which increases blood clot risk fourfold.GlobeNewswireCatalyst Biosciences Announces Presentations at the International Society on Thrombosis and HaemostasisCatalyst Biosciences announced four poster presentations on marzaptacog alfa (activated) and dalcinanonog alfa at the ISTH Virtual Congress from July 17-21, 2021. The posters cover dose selection, subcutaneous efficacy in FVII deficiency, and mitigation of injection site reactions. Presentation materials will be available on the company's website once the congress begins.PR NewswireOrganizations Collaborate to Develop International State-of-the-Art Guidelines on the Diagnosis and Management of von Willebrand DiseaseFour medical organizations—the American Society of Hematology, International Society on Thrombosis and Haemostasis, National Hemophilia Foundation, and World Federation of Hemophilia—published joint clinical practice guidelines in Blood Advances on January 12, 2021, for the diagnosis and management of von Willebrand Disease, the world's most common inherited bleeding disorder affecting approximately 1% of the global population. The guidelines contain 19 combined recommendations and, for the first time, recommend routine VWD prophylaxis with injectable clotting protein for patients who suffer from frequent, severe bleeding that decreases quality of life. The collaborating organizations plan to develop educational resources and tools to support clinicians and patients worldwide in implementing these recommendations.PR NewswireLa campaña del Día mundial de la trombosis destaca la conexión potencialmente fatal entre la trombosis y la COVID-19The International Society on Thrombosis and Haemostasis (ISTH) launched its 2020 World Thrombosis Day campaign to highlight the link between thrombosis and COVID-19. The initiative aims to educate healthcare professionals and patients about the risks of blood clots, particularly in hospitalized patients and those with severe COVID-19 symptoms.GlobeNewswireFreeline announces acceptance of Late Breaking Abstract at the International Society on Thrombosis and Haemostasis (ISTH) 2020 MeetingFreeline announced that Professor Pratima Chowdary will present data on its FLT180a gene therapy in a late-breaking abstract at the ISTH 2020 Congress, held virtually July 12-14. The company also has five posters, including data on the Factor IX Padua variant and health economics. The abstract reports normal FIX activity levels in severe haemophilia B patients.PR NewswireWorld Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood ClotsThe World Thrombosis Day campaign, led by the International Society on Thrombosis and Haemostasis (ISTH), is raising awareness about hospital-acquired blood clots on October 13, 2019, emphasizing that one in four deaths globally are linked to thrombosis-related conditions. The article highlights that approximately 10 million cases of venous thromboembolism occur annually worldwide, with 60 percent of blood clots linked to hospitalization. England is cited as a success case, having achieved a 15.4 percent reduction in deaths within 90 days after hospital discharge since 2010, thanks to mandated VTE prevention measures by the National Health Service.